Home › Science › Bacterial Couriers Deliver Drugs Into
SCIENCE
Bacterial Couriers Deliver Drugs Into Cancers
Nature reports on innovative therapies using genetically engineered bacteria to deliver molecules directly to tumours.
By Xentir Media Newsroom · Editorial standards by Jomon · September 10, 2026 · 1 min read
WHAT YOU NEED TO KNOW
John Heller was diagnosed with advanced pancreatic cancer in the summer of 2023.
Daniel Saltzman developed a therapy using genetically engineered Salmonella Typhimurium bacteria.
The therapy delivers interleukin-2, an immune-system-activating molecule, to tumours.
Nature reported on an innovative therapy developed by surgeon Daniel Saltzman at the University of Minnesota in Minneapolis.
Patient John Heller was diagnosed with advanced pancreatic cancer in the summer of 2023 and began chemotherapy with an expected survival of about a year.
Saltzman developed a therapy using genetically engineered Salmonella Typhimurium bacteria to deliver interleukin-2, a potent immune-system-activating molecule, directly to tumours.
Xentir Media NewsroomSource-backed AI and technology coverage, drafted by Xentir's automated editorial system under fixed human-set rules. See our editorial policy and AI usage policy.
Jomon · Founder & EditorFounder and editor of Xentir Media. Sets the editorial rules the newsroom system runs under, and is accountable for its corrections. About Jomon · [email protected]
The Xentir Brief The developments worth knowing — one useful email. Get the Brief →
